67 related articles for article (PubMed ID: 14996948)
1. Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells.
Kam AY; Chan AS; Wong YH
J Pharmacol Exp Ther; 2004 Jul; 310(1):301-10. PubMed ID: 14996948
[TBL] [Abstract][Full Text] [Related]
2. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.
Oktay M; Wary KK; Dans M; Birge RB; Giancotti FG
J Cell Biol; 1999 Jun; 145(7):1461-9. PubMed ID: 10385525
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of FAK signaling by SOCS proteins.
Liu E; Côté JF; Vuori K
EMBO J; 2003 Oct; 22(19):5036-46. PubMed ID: 14517242
[TBL] [Abstract][Full Text] [Related]
4. PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway.
Dong C; Li X; Yang J; Yuan D; Zhou Y; Zhang Y; Shi G; Zhang R; Liu J; Fu P; Sun M
Cell Death Dis; 2021 Sep; 12(9):827. PubMed ID: 34480020
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association.
Thomas W; Pullinger GD; Lax AJ; Rozengurt E
Infect Immun; 2001 Sep; 69(9):5931-5. PubMed ID: 11500476
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor phosphorylation contributes to levobupivacaine-induced contraction in isolated rat aorta.
Lee SH; Ok SH; Park KE; Bae SI; Hwang Y; Ahn SH; Sim G; Bae M; Sohn JT
Eur J Pharmacol; 2024 Mar; 967():176389. PubMed ID: 38311282
[TBL] [Abstract][Full Text] [Related]
7. Src redox regulation: there is more than meets the eye.
Chiarugi P
Mol Cells; 2008 Oct; 26(4):329-37. PubMed ID: 18772619
[TBL] [Abstract][Full Text] [Related]
8. Activation of RhoA, Smad2, c-Src, PKC-βII/δ and JNK in atopic dermatitis.
Lu J; Yin R; Fu Z; Lee VM; Nelson JS; Tan W
Australas J Dermatol; 2018 Nov; 59(4):e258-e261. PubMed ID: 29498756
[TBL] [Abstract][Full Text] [Related]
9. FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs.
Griffith BGC; Upstill-Goddard R; Brunton H; Grimes GR; Biankin AV; Serrels B; Byron A; Frame MC
Sci Rep; 2021 Jan; 11(1):229. PubMed ID: 33420223
[TBL] [Abstract][Full Text] [Related]
10. Retraction Note: Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways.
Zubkova E; Semenkova L; Dudich E; Dudich I; Parfyonova Y; Menshikov M
Mol Cell Biochem; 2023 Nov; 478(11):2607. PubMed ID: 36807873
[No Abstract] [Full Text] [Related]
11. Synthesis and Antiproliferative Activity against Cancer Cells of Indole-Aryl-Amide Derivatives.
Zhao J; Carbone J; Farruggia G; Janecka A; Gentilucci L; Calonghi N
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615458
[TBL] [Abstract][Full Text] [Related]
12. Opioids in cancer: The κ‑opioid receptor (Review).
Zhou Q; Zhang Z; Long S; Li W; Wang B; Liang N
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878160
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptors signaling network.
Gopalakrishnan L; Chatterjee O; Ravishankar N; Suresh S; Raju R; Mahadevan A; Prasad TSK
J Cell Commun Signal; 2022 Sep; 16(3):475-483. PubMed ID: 34724150
[TBL] [Abstract][Full Text] [Related]
14. Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms.
Kuhar JR; Bedini A; Melief EJ; Chiu YC; Striegel HN; Chavkin C
Cell Signal; 2015 Sep; 27(9):1799-806. PubMed ID: 26056051
[TBL] [Abstract][Full Text] [Related]
15. Role of kappa-opioid receptors in stress and anxiety-related behavior.
Van't Veer A; Carlezon WA
Psychopharmacology (Berl); 2013 Oct; 229(3):435-52. PubMed ID: 23836029
[TBL] [Abstract][Full Text] [Related]
16. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
Gillett K; Harshberger E; Valdez GR
Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692
[TBL] [Abstract][Full Text] [Related]
17. Development of κ opioid receptor antagonists.
Carroll FI; Carlezon WA
J Med Chem; 2013 Mar; 56(6):2178-95. PubMed ID: 23360448
[TBL] [Abstract][Full Text] [Related]
18. Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells.
Kuzumaki N; Suzuki A; Narita M; Hosoya T; Nagasawa A; Imai S; Yamamizu K; Morita H; Nagase H; Okada Y; Okano HJ; Yamashita JK; Okano H; Suzuki T; Narita M
Br J Cancer; 2012 Mar; 106(6):1148-52. PubMed ID: 22343623
[TBL] [Abstract][Full Text] [Related]
19. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
Tejeda HA; Shippenberg TS; Henriksson R
Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin, stress, and depression.
Knoll AT; Carlezon WA
Brain Res; 2010 Feb; 1314():56-73. PubMed ID: 19782055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
